{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T13:34:05Z","timestamp":1782567245867,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-025-02800-4","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T14:14:47Z","timestamp":1767622487000},"page":"1049-1057","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect on insulin clearance of different pharmacological treatments in women with polycystic ovary syndrome: a hypothesis-generative study"],"prefix":"10.1007","volume":"49","author":[{"given":"Flavia","family":"Tosi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elisabetta","family":"Zanolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Garofalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Gremes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Zoppini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3951-0297","authenticated-orcid":false,"given":"Paolo","family":"Moghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"2800_CR1","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/er.2011-1034","volume":"33","author":"E Diamanti-Kandarakis","year":"2012","unstructured":"Diamanti-Kandarakis E, Dunaif A (2012) Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev 33:981\u20131030. https:\/\/doi.org\/10.1210\/er.2011-1034","journal-title":"Endocr Rev"},{"key":"2800_CR2","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1093\/humrep\/deaf114","volume":"40","author":"F Tosi","year":"2025","unstructured":"Tosi F, Lando MG et al (2025) Alterations of insulin sensitivity, clearance, and secretion, either alone or in combination, in women with PCOS: impact on metabolic profile and androgenemia. Hum Reprod 40:1550\u20131561. https:\/\/doi.org\/10.1093\/humrep\/deaf114","journal-title":"Hum Reprod"},{"issue":"2","key":"2800_CR3","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-24-0269","volume":"265","author":"EJ Houston","year":"2025","unstructured":"Houston EJ, Templeman NM (2025) Reappraising the relationship between hyperinsulinemia and insulin resistance in PCOS. J Endocrinol 265(2):e240269. https:\/\/doi.org\/10.1530\/JOE-24-0269","journal-title":"J Endocrinol"},{"key":"2800_CR4","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1210\/jcem.83.6.4886","volume":"83","author":"JE Nestler","year":"1998","unstructured":"Nestler JE, Jakubowicz DJ, de Vergas AF, Brik C, Quintero N, Medina F (1998) Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab 83:2001\u20132005. https:\/\/doi.org\/10.1210\/jcem.83.6.4886","journal-title":"J Clin Endocrinol Metab"},{"key":"2800_CR5","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1210\/jc.2011-2939","volume":"97","author":"F Tosi","year":"2012","unstructured":"Tosi F, Negri C, Perrone F, Dorizzi R, Castello R, Bonora E, Moghetti P (2012) Hyperinsulinemia amplifies GnRH agonist stimulated ovarian steroid secretion in women with polycystic ovary syndrome. J Clin Endocrinol Metab 97:1712\u20131719. https:\/\/doi.org\/10.1210\/jc.2011-2939","journal-title":"J Clin Endocrinol Metab"},{"key":"2800_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1530\/EJE-10-0782","volume":"164","author":"F Tosi","year":"2011","unstructured":"Tosi F, Negri C et al (2011) Insulin enhances ACTH-stimulated androgen and glucocorticoid metabolism in hyperandrogenic women. Eur J Endocrinol 164:197\u2013203. https:\/\/doi.org\/10.1530\/EJE-10-0782","journal-title":"Eur J Endocrinol"},{"key":"2800_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1210\/jcem-72-1-83","volume":"72","author":"JE Nestler","year":"1991","unstructured":"Nestler JE, Powers LP et al (1991) A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 72:83\u201389. https:\/\/doi.org\/10.1210\/jcem-72-1-83","journal-title":"J Clin Endocrinol Metab"},{"key":"2800_CR8","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1210\/edrv.19.5.0349","volume":"19","author":"WC Duckworth","year":"1998","unstructured":"Duckworth WC, Bennett RG, Hamel FG (1998) Insulin degradation: progress and potential. Endocr Rev 19:608\u2013624. https:\/\/doi.org\/10.1210\/edrv.19.5.0349","journal-title":"Endocr Rev"},{"key":"2800_CR9","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1046\/j.1464-5491.2002.00794.x","volume":"19","author":"E Ferrannini","year":"2002","unstructured":"Ferrannini E, Balkau B (2002) Insulin: in search of a syndrome. Diabet Med 19:724\u2013729. https:\/\/doi.org\/10.1046\/j.1464-5491.2002.00794.x","journal-title":"Diabet Med"},{"key":"2800_CR10","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s40618-015-0372-x","volume":"38","author":"MC Amato","year":"2015","unstructured":"Amato MC, Vesco R, Vigneri E, Ciresi A, Giordano C (2015) Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance. J Endocrinol Invest 38:1319\u20131326. https:\/\/doi.org\/10.1007\/s40618-015-0372-x","journal-title":"J Endocrinol Invest"},{"key":"2800_CR11","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1093\/humrep\/12.9.1897","volume":"12","author":"M Ciampelli","year":"1997","unstructured":"Ciampelli M, Fulghesu AM et al (1997) Heterogeneity in b cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome. Hum Reprod 12:1897\u20131901. https:\/\/doi.org\/10.1093\/humrep\/12.9.1897","journal-title":"Hum Reprod"},{"key":"2800_CR12","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/0026-0495(94)90029-9","volume":"43","author":"CK Buffington","year":"1994","unstructured":"Buffington CK, Kitabchi AE (1994) Evidence for a defect in insulin metabolism in hyperandrogenic women with polycystic ovarian syndrome. Metabolism 43:1367\u20131372. https:\/\/doi.org\/10.1016\/0026-0495(94)90029-9","journal-title":"Metabolism"},{"key":"2800_CR13","doi-asserted-by":"publisher","first-page":"e1981","DOI":"10.1210\/clinem\/dgaa095","volume":"105","author":"F Tosi","year":"2020","unstructured":"Tosi F, Dal Molin F et al (2020) Serum androgens are independent predictors of insulin clearance but not of insulin secretion in women with PCOS. J Clin Endocrinol Metab 105:e1981-1989. https:\/\/doi.org\/10.1210\/clinem\/dgaa095","journal-title":"J Clin Endocrinol Metab"},{"key":"2800_CR14","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1210\/jcem.85.9.6792","volume":"85","author":"LC Morin-Papunen","year":"2000","unstructured":"Morin-Papunen LC, Vauhkonen I, Koivunen RM, Ruokonen A, Martikainen HK, Tapanainen JS (2000) Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study. J Clin Endocrinol Metab 85:3161\u20133168. https:\/\/doi.org\/10.1210\/jcem.85.9.6792","journal-title":"J Clin Endocrinol Metab"},{"key":"2800_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1210\/jc.2002-020997","volume":"88","author":"L Morin-Papunen","year":"2003","unstructured":"Morin-Papunen L, Vauhkonen I, Koivunen R, Ruokonen A, Martikainen H, Tapanainen JS (2003) Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study. J Clin Endocrinol Metab 88:148\u2013156. https:\/\/doi.org\/10.1210\/jc.2002-020997","journal-title":"J Clin Endocrinol Metab"},{"key":"2800_CR16","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1210\/jc.2003-030328","volume":"88","author":"A Cagnacci","year":"2003","unstructured":"Cagnacci A, Paoletti AM, Renzi A, Orr\u00f9 M, Pilloni M, Melis GB, Volpe A (2003) Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel. J Clin Endocrinol Metab 88:3621\u20133625. https:\/\/doi.org\/10.1210\/jc.2003-030328","journal-title":"J Clin Endocrinol Metab"},{"issue":"1210","key":"2800_CR17","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/humrep\/deg264","volume":"18","author":"D Romualdi","year":"2003","unstructured":"Romualdi D, Guido M, Ciampelli M, Giuliani M, Leoni F, Perri C, Lanzone A (2003) Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome. Hum Reprod 18(1210):1218. https:\/\/doi.org\/10.1093\/humrep\/deg264","journal-title":"Hum Reprod"},{"key":"2800_CR18","doi-asserted-by":"publisher","first-page":"486","DOI":"10.2337\/diab.33.5.486","volume":"33","author":"KS Polonsky","year":"1984","unstructured":"Polonsky KS, Rubenstein AH (1984) C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations. Diabetes 33:486\u2013494. https:\/\/doi.org\/10.2337\/diab.33.5.486","journal-title":"Diabetes"},{"key":"2800_CR19","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1210\/jcem.81.3.8772557","volume":"81","author":"P Moghetti","year":"1996","unstructured":"Moghetti P, Tosi F et al (1996) The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women. J Clin Endocrinol Metab 81:952\u2013960. https:\/\/doi.org\/10.1210\/jcem.81.3.8772557","journal-title":"J Clin Endocrinol Metab"},{"key":"2800_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1210\/jcem.85.1.6293","volume":"85","author":"P Moghetti","year":"2000","unstructured":"Moghetti P, Castello R et al (2000) Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 85:139\u2013146. https:\/\/doi.org\/10.1210\/jcem.85.1.6293","journal-title":"J Clin Endocrinol Metab"},{"key":"2800_CR21","first-page":"377","volume-title":"Polycystic Ovary Syndrome","author":"JK Zawadzki","year":"1992","unstructured":"Zawadzki JK, Dunaif A (1992) Diagnostic criteria for Polycystic Ovary Syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR (eds) Polycystic Ovary Syndrome. Blackwell Scientific Publications, Cambridge MA p, pp 377\u2013384"},{"key":"2800_CR22","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1093\/humupd\/dmr042","volume":"18","author":"HF Escobar-Morreale","year":"2012","unstructured":"Escobar-Morreale HF, Carmina E et al (2012) Epidemiology, diagnosis and management of hirsutism: a consensus statement by the androgen excess and polycystic ovary syndrome society. Hum Reprod Update 18:146\u2013170. https:\/\/doi.org\/10.1093\/humupd\/dmr042","journal-title":"Hum Reprod Update"},{"key":"2800_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/ajcn\/50.2.255","volume":"50","author":"DS Gray","year":"1989","unstructured":"Gray DS, Bray GA, Gemayel N, Kaplan K (1989) Effect of obesity on bioelectrical impedance. Am J Clin Nutr 50:255\u2013260. https:\/\/doi.org\/10.1093\/ajcn\/50.2.255","journal-title":"Am J Clin Nutr"},{"key":"2800_CR24","first-page":"1","volume":"727","author":"World Health Organization Study Group","year":"1985","unstructured":"World Health Organization Study Group (1985) Diabetes mellitus. World Health Organization Technical Report Series 727:1\u2013113","journal-title":"World Health Organization Technical Report Series"},{"key":"2800_CR25","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1979.237.3.E214","volume":"237","author":"RA DeFronzo","year":"1979","unstructured":"DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-223. https:\/\/doi.org\/10.1152\/ajpendo.1979.237.3.E214","journal-title":"Am J Physiol"},{"key":"2800_CR26","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2337\/diab.37.6.667","volume":"37","author":"RA DeFronzo","year":"1988","unstructured":"DeFronzo RA (1988) The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37:667\u2013687. https:\/\/doi.org\/10.2337\/diab.37.6.667","journal-title":"Diabetes"},{"key":"2800_CR27","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1097\/00004872-199816070-00001","volume":"16","author":"E Ferrannini","year":"1988","unstructured":"Ferrannini E, Mari A (1988) How to measure insulin sensitivity. J Hypertens 16:895\u2013906. https:\/\/doi.org\/10.1097\/00004872-199816070-00001","journal-title":"J Hypertens"},{"key":"2800_CR28","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419. https:\/\/doi.org\/10.1007\/BF00280883","journal-title":"Diabetologia"},{"key":"2800_CR29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s40618-020-01351-0","volume":"44","author":"P Moghetti","year":"2021","unstructured":"Moghetti P, Tosi F (2021) Insulin resistance and PCOS: chicken or egg? J Endocrinol Invest 44:233\u2013244. https:\/\/doi.org\/10.1007\/s40618-020-01351-0","journal-title":"J Endocrinol Invest"},{"key":"2800_CR30","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.2337\/db20-0377","volume":"69","author":"S van Vliet","year":"2020","unstructured":"van Vliet S, Koh HE et al (2020) Obesity is associated with increased basal and postprandial \u03b2-cell insulin secretion even in the absence of insulin resistance. Diabetes 69:2112\u20132119. https:\/\/doi.org\/10.2337\/db20-0377","journal-title":"Diabetes"},{"issue":"3","key":"2800_CR31","doi-asserted-by":"publisher","DOI":"10.1172\/JCI154068","volume":"132","author":"B Mittendorfer","year":"2022","unstructured":"Mittendorfer B, Patterson BW, Smith GI, Yoshino M, Klein S (2022) \u03b2 cell function and plasma insulin clearance in people with obesity and different glycemic status. J Clin Invest 132(3):e154068. https:\/\/doi.org\/10.1172\/JCI154068","journal-title":"J Clin Invest"},{"key":"2800_CR32","doi-asserted-by":"publisher","first-page":"570","DOI":"10.2337\/diab.39.5.570","volume":"39","author":"J Svedberg","year":"1990","unstructured":"Svedberg J, Bjorntorp P, Smith U, Lonnroth P (1990) Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes 39:570\u2013574. https:\/\/doi.org\/10.2337\/diab.39.5.570","journal-title":"Diabetes"},{"key":"2800_CR33","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3390\/jcm10030390","volume":"10","author":"A London","year":"2021","unstructured":"London A, Lundsgaard A-M, Kiens B, Nyvold Bojsen-M\u00f8ller K (2021) The role of hepatic fat accumulation in glucose and insulin homeostasis-dysregulation by the liver. J Clin Med 10:390. https:\/\/doi.org\/10.3390\/jcm10030390","journal-title":"J Clin Med"},{"key":"2800_CR34","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1056\/NEJM199803263381303","volume":"338","author":"SE Inzucchi","year":"1998","unstructured":"Inzucchi SE, Maggs DG, Spollett GR, Page SL, Rife FS, Walton V, Shulman GI (1998) Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N Engl J Med 338:867\u201372. https:\/\/doi.org\/10.1056\/NEJM199803263381303","journal-title":"N Engl J Med"},{"key":"2800_CR35","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1136\/jim-2016-000149","volume":"64","author":"SH Kim","year":"2016","unstructured":"Kim SH, Reaven GM (2016) Insulin clearance: an underappreciated modulator of plasma insulin concentration. J Investig Med 64:1162\u20131165. https:\/\/doi.org\/10.1136\/jim-2016-000149","journal-title":"J Investig Med"},{"key":"2800_CR36","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.2337\/diabetes.53.8.2169","volume":"53","author":"M Tiikkainen","year":"2004","unstructured":"Tiikkainen M, H\u00e4kkinen AM, Korsheninnikova E, Nyman T, M\u00e4kimattila S, Yki-J\u00e4rvinen H (2004) Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes. Diabetes 53:2169\u20132176. https:\/\/doi.org\/10.2337\/diabetes.53.8.2169","journal-title":"Diabetes"},{"key":"2800_CR37","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1055\/s-0035-156928","volume":"48","author":"JR Su","year":"2016","unstructured":"Su JR, Lu ZH et al (2016) Relationship of serum adiponectin levels and metformin therapy in patients with type 2 diabetes. Horm Metab Res 48:92\u201398. https:\/\/doi.org\/10.1055\/s-0035-156928","journal-title":"Horm Metab Res"},{"key":"2800_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140565","volume":"10","author":"W Kong","year":"2015","unstructured":"Kong W, Niu X, Zeng T, Lu M, Chen L (2015) Impact of treatment with metformin on adipocytokines in patients with Polycystic Ovary Syndrome: a meta-analysis. PLOS ONE 10:e0140565. https:\/\/doi.org\/10.1371\/journal.pone.0140565","journal-title":"PLOS ONE"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02800-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-025-02800-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02800-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T10:11:26Z","timestamp":1776247886000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-025-02800-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["2800"],"URL":"https:\/\/doi.org\/10.1007\/s40618-025-02800-4","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}